Sarim Hassan Shahab

Sarim Hassan Shahab

Auto-generated profile, based on publicly available information

Sarim Hassan Shahab

Nishtar Medical University Multan Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2026 in The Egyptian Journal of Bronchology
Verified
Journal Article
Open access
SSSarim Hassan Shahab
Sarim Hassan Shahab
MMMehreen Maka
Mehreen Maka
SASiddique Ahmed
Siddique Ahmed
WIWarda Imran
Warda Imran
AHAoun Hassan
Aoun Hassan
OGOmar Abdullah Gill
Omar Abdullah Gill
Background: Both lung cancer and diabetes are the leading causes of death worldwide. These two conditions commonly coexist, especially in older patients, and result in worsening of prognosis and lower survival rates. Very limited scientific data are available about their correlation. Studying the mortality trends using data from Centers for Disease Control and Prevention Wide-Ranging Online Data of Epidemiologic Research (CDC WONDER) can help us in designing better health policies and treatment strategies. Methods: We analyzed the US mortality data from 1999 to 2023 using the CDC WONDER dataset. The ICD-10 codes were used. For lung cancer, it is C34, and for diabetes, they are E10-14. Temporal trends were analyzed by using joinpoint regression (V5.4.0) and a p value < 0.05 was considered statistically significant. Results: From 1999 to 2023, a total of 174,418 deaths were reported in the United States. Most of them occurred at home (39.6%), followed by medical facilities (33.8%). Men had mortality rates approximately twice as high as those of women. Non-Hispanic Black individuals had age adjusted mortality rates (AAMRs) approximately 2 to 3 times higher than other racial groups, peaking at 5.28 in 2005, followed by NH White, NH Other, and Hispanic or Latino, respectively. Rural areas consistently exhibited higher mortality rates. The highest AAMR was found in Kentucky (5.70), followed by West Virginia (5.24) and Oklahoma (4.94). The Southern states had a higher mortality burden. Conclusion: The rate of mortality due to lung cancer in diabetics continued to rise, with significant disparities. The research emphasizes the need for smoking cessation strategies, integrated care of diabetes and oncology, and equitable health care access to reduce the disparities. Graphical

10 July 2026 in Medicine
Verified
Journal Article
Open access
ZYZarqa Yasin
Zarqa Yasin
NSNoor ul Ain Saleem
Noor ul Ain Saleem
BSBipneet Singh
Bipneet Singh
SSSarim Hassan Shahab
Sarim Hassan Shahab
AGAbdrabo Gamal
Abdrabo Gamal
UNUrsula Abu Nahla
Ursula Abu Nahla
Gastrointestinal obstruction is an important cause of morbidity and mortality in the United States, but full descriptions of time trends and disparities are poorly defined. This study aims to examine trends in mortality from gastrointestinal obstruction over a span of 25 years in various demographics and geographic locations within the United States from 1999 to 2023. We conducted a retrospective analysis using CDC WONDER multiple cause-of-death data. Deaths were identified when gastrointestinal obstruction was listed as either the underlying or a contributing cause of death. Age-adjusted mortality rates (AAMR) per 1,00,000 population were calculated and stratified by sex, race/ethnicity, census region, urbanization level, and state. Joinpoint regression analysis identified inflection points and estimated annual percent changes (APC) and average annual percent changes. Between 1999 and 2023, 5,20,045 deaths from gastrointestinal obstruction were identified. Overall, AAMR declined from 10.76 per 1,00,000 in 1999 to 8.56 in 2014, followed by an increase to 9.95 in 2023. Joinpoint analysis revealed 3 distinct phases: significant decline (1999–2012, APC −1.78%, P < .001), plateau (2012–2018, APC −0.09%, P = .862), and significant increase (2018–2023, APC 3.43%, P < .001). Males consistently exhibited higher mortality than females throughout the study period (2023: 10.44 vs 9.59 per 1,00,000). Substantial racial disparities persisted, with non-Hispanic Black individuals demonstrating the highest AAMR (12.95 in 2023), 1.32-fold higher than non-Hispanic white individuals. Rural areas maintained consistently higher mortality than urban areas; data from 2020 are presented for urbanization comparisons, as this was the most recent year with complete rural-urban classification data available from CDC WONDER at the time of analysis (2020: 10.99 vs 8.54 per 1,00,000). State-level age-adjusted mortality rates varied nearly 2-fold, ranging from 6.86 in Florida to 13.15 in Vermont. Most deaths occurred in medical facilities (66.8%). After a decade of declining gastrointestinal obstruction mortality, rates have increased significantly since 2018 across nearly all demographic groups. Persistent disparities by race, geography, and urbanization underscore the need for targeted interventions and equitable access to timely surgical care. The reversal of favorable trends warrants urgent investigation into contributing factors and implementation of prevention strategies.

15 May 2026 in Medicine
Verified
Journal Article
Open access
SSSarim Hassan Mbbs Shahab
Sarim Hassan Mbbs Shahab
ZMZuha Mbbs Maryam
Zuha Mbbs Maryam
SNSyeda Malika Mbbs Naqvi
Syeda Malika Mbbs Naqvi
MAMuhammad Mbbs Ahmed
Muhammad Mbbs Ahmed
AMAlisha Mbbs Matloob
Alisha Mbbs Matloob
URUbaid Ur Mbbs Rehman
Ubaid Ur Mbbs Rehman
This study aims to examine the national trends and disparities in mortality caused by liver failure among adult patients diagnosed with mental and behavioral disorders (MBDs) that are attributable to tobacco use in the United States using the Centers for Disease Control and Prevention (CDC) Wide-ranging online data for epidemiologic research mortality data. Understanding these trends is essential to identifying high-risk populations and informing targeted screening and early intervention strategies. The findings can guide integrated smoking cessation and liver disease management efforts to reduce preventable mortality in vulnerable groups. This descriptive study utilized CDC WONDER data for adults aged 25 years and older. Mortality cases were identified using the International Classification of Diseases, tenth revision codes K72 (Liver failure) and F17 (MBD due to tobacco use). Age-adjusted mortality rates (AAMRs) per 100,000 were computed and stratified by gender, race/ethnicity, census region, Urban-Rural status, and state. Joinpoint regression was applied to estimate annual percent changes with 95% confidence intervals, and statistical significance was defined as P < .05. A total of 46,227 deaths were analyzed, with most occurring in medical facilities (61.7%), followed by homes and nursing facilities. The overall AAMR rose from 0.074 in 1999 to 0.94 in 2020 and then slightly declined to 0.78 by 2023. Both females and males showed similar upward trends, with males having higher AAMRs. Non-Hispanic Whites experienced the largest long-term increase, while Hispanic and Black populations showed recent declines. Mortality increased more sharply in rural areas as compared to urban areas, and regionally, the Midwest and South had sharp rises. State-level rates were highest in North Dakota, Wyoming, and South Dakota and lowest in California, Virginia, and Massachusetts, highlighting significant geographic disparities in liver failure mortality among adults with MBDs due to tobacco use. Deaths due to liver failure in adults with MBDs due to tobacco use in the United States increased substantially in the last 20 years, with significant demographic and regional inequalities. These results indicate the necessity of targeted prevention, smoking cessation programs, and equitable healthcare policies in order to decrease the mortality rate.

26 June 2026 in Medicine
Verified
Journal Article
Open access
SSSarim Hassan Shahab
Sarim Hassan Shahab
MJMuhammad Hassaan Javaid
Muhammad Hassaan Javaid
HMHadia Ghazala Masood
Hadia Ghazala Masood
SMSanhia Maheshwari
Sanhia Maheshwari
MAMuhammad Ahmed
Muhammad Ahmed
FHFazal Habib
Fazal Habib
Chronic kidney disease (CKD) attributable to type 2 diabetes mellitus represents a substantial contributor to morbidity and mortality across Asia; however, comprehensive evaluations of long-term trends and regional heterogeneity remain limited. This study quantified the burden and temporal trends of CKD due to type 2 diabetes mellitus in Asia using estimates from the Global Burden of Disease (GBD) study. We estimated age-standardized incidence, prevalence, and mortality of CKD due to chronic kidney disease attributable to type 2 diabetes mellitus across Asia and its sub-regions using GBD data, with Asia-level estimates available through 2021 and sub-regional estimates through 2023. We performed Joinpoint regression analysis, with permutation tests (National Cancer Institute Joinpoint version 5.2.0), to imply significant changes in inflection points. Calculations for Annual Percentage Changes (APCs) and average annual percent changes (AAPCs) with 95% confidence intervals were also carried out. In 2021, an estimated 69.15 million individuals (95% UI: 53.73–74.77 million) in Asia were living with CKD attributable to chronic kidney disease attributable to type 2 diabetes mellitus, corresponding to an age-standardized prevalence rate (ASPR) of 1354 per 100,000 population (95% UI: 1248–1464). The age-standardized incidence rate (ASIR) was 20.26 (95% UI: 18.68–21.72) per 100,000, while the age-standardized death rate (ASDR) was 6.04 (95% UI: 5.08–7.21). From 1990 to 2021, ASPR declined modestly (AAPC: −0.28%), whereas ASIR increased (AAPC: 0.52%) and ASDR remained largely stable. Marked regional disparities were observed. Central Asia demonstrated sustained increases in prevalence, incidence, and mortality, including a rising ASDR between 1980 and 2023 (AAPC: 0.81%; 95% CI: 0.21–1.41). East Asia showed increasing prevalence alongside declining incidence and mortality, while Southeast Asia exhibited rising prevalence and incidence with decreasing mortality. Males consistently had higher prevalence, incidence, and mortality than females. The CKD in type 2 diabetics showed much regional variation throughout Asia. Although improvements in incidence and mortality were observed, the persistently high prevalence signifies a rapidly expanding population of diabetic CKD individuals. These findings underscore the urgent necessity for region-specific diabetes prevention and targeted health policies.

20 February 2026 in Medicine
Verified
Journal Article
Open access
SSSarim Hassan Shahab
Sarim Hassan Shahab
SJSaim Jan
Saim Jan
AWAbdul Wasay
Abdul Wasay
SNSyeda Malika Naqvi
Syeda Malika Naqvi
MUMuhammad Umar
Muhammad Umar
FHFazal Habib
Fazal Habib
This study aims to examine long-term trends in age-adjusted mortality rate associated with cardiac arrhythmias among anemic adults in the United States from 1999 to 2023 and assess disparities by sex, race/ethnicity, geographic region, and urban–rural residence. For this retrospective observational study, the data was extracted from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research. International classification of disease (ICD)-10 codes were used to identify cardiac arrhythmia and anemia. We used Joinpoint Regression Program (V.5.4.0) for the analysis of trends and a P -value of <.05 was considered statistically significant. The overall age-adjusted mortality rate for cardiac arrhythmia in anemic patients increased from 2.30 in 1999 to 5.03 in 2023, showing a more than 2-fold rise over the 25-year period. Males consistently had a higher mortality than females, rising from 2.64 to 6.11 in men and from 2.09 to 4.28 in women between 1999 and 2023. Non-Hispanic (NH) White adults had the highest mortality, followed by NH Blacks or African American, Hispanics, and NH others respectively throughout 1999 to 2023. Highest mortality rates were observed in Rhode Island, West Virginia, Ohio, and Vermont. Rural areas had higher mortality than urban areas, rising from 2.52 to 5.63 compared with 2.24 to 4.14 in urban areas between 1999 and 2020. The highest mortality rates were in the midwest and south. In conclusion, mortality from cardiac arrhythmias in anemic adults has increased significantly over the past 25 years. There are disparities by sex, race, region, and rural versus urban setting that suggest the need for focused interventions and targeted policy design for vulnerable communities to avoid preventable deaths.

24 September 2026 in Journal of Diabetes & Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
FMFaizan E. Mustafa
Faizan E. Mustafa
SSSarim Hassan Shahab
Sarim Hassan Shahab
SNSyeda Malika Naqvi
Syeda Malika Naqvi
ISIrza Shaikh
Irza Shaikh
HMHadia Ghazala Masood
Hadia Ghazala Masood
MKMuddassir Khalid
Muddassir Khalid